Mylan Pharmaceuticals
Recent News About Mylan Pharmaceuticals
-
May 3: U.S. District Court for the Western District of Pennsylvania docket for "835 patent - abbreviated new drug application(anda)" cases
The following cases categorized as "835 patent - abbreviated new drug application(anda)" were on the docket in the U.S. District Court for the Western District of Pennsylvania on May 3. All case details are allegations only and should not be taken as fact: -
U.S. District Court for the Western District of Pennsylvania: Actions Taken on May 3
The U.S. District Court for the Western District of Pennsylvania reported the following activity on May 3 in the suits below: -
U.S. District Court for the Western District of Pennsylvania: Actions Taken on April 30
The U.S. District Court for the Western District of Pennsylvania reported the following activity on April 30 in the suits below: -
April 30: U.S. District Court for the Western District of Pennsylvania docket for "835 patent - abbreviated new drug application(anda)" cases
The following cases categorized as "835 patent - abbreviated new drug application(anda)" were on the docket in the U.S. District Court for the Western District of Pennsylvania on April 30. All case details are allegations only and should not be taken as fact: -
Case activity for Bausch Health Ireland Limited vs Mylan Laboratories Ltd. on April 30
The U.S. District Court for the Western District of Pennsylvania reported the following activities in the suit brought by Bausch Health Ireland Limited and Salix Pharmaceuticals Inc. against Agila Specialties Inc., Mylan Api USA LLC, Mylan Inc., Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc. and Viatris Inc. on April 30. -
Court activity on May 3: Bausch Health Ireland Limited vs Mylan Laboratories Ltd.
The U.S. District Court for the Western District of Pennsylvania reported the following activity in the suit brought by Bausch Health Ireland Limited and Salix Pharmaceuticals Inc. against Agila Specialties Inc., Mylan Api USA LLC, Mylan Inc., Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc. and Viatris Inc. on May 3. -
Oct. 19: U.S. District Court for the Eastern District of Pennsylvania docket for "personal injury" cases
The following cases categorized as "personal injury" were on the docket in the U.S. District Court for the Eastern District of Pennsylvania on Oct. 19. All case details are allegations only and should not be taken as fact: -
U.S. District Court for the Eastern District of Pennsylvania: Actions Taken on Oct. 19
The U.S. District Court for the Eastern District of Pennsylvania reported the following activity on Oct. 19 in the suits below: -
Court activity on Oct. 19: Asbestos Workers Local Union No. 2 Welfare Fund vs Endo Pharmaceuticals Inc.
The U.S. District Court for the Eastern District of Pennsylvania reported the following activity in the suit brought by Asbestos Workers Local Union No. 2 Welfare Fund against Endo Pharmaceuticals Inc. on Oct. 19. -
Label or Liability: GSK faces $3M verdict over product it didn't make
CHICAGO - This spring, a Chicago federal jury awarded $3 million to the widow of a lawyer who committed suicide by stepping in front of a CTA L train in Chicago’s Loop in 2010 shortly after taking a generic version of the antidepressant drug Paxil. -
Third Circuit decision in product-hopping case may be at odds with prior case, attorney says
PHILADELPHIA – A decision out of the U.S. Court of Appeals for the Third Circuit earlier this fall that a pharmaceutical company in a Pennsylvania product-hopping case did not violate the Sherman Antitrust Act seems to be at odds with a prior precedent-setting case, a Washington, D.C.-based attorney says. -
Fentanyl Patch overdose spurs wrongful death claim against drug manufacturers
The spouse of a woman who allegedly died as a result of using a Fentanyl pain patch has filed suit in state court against the companies involved in the manufacture, design and sale of the product. -
Makers of fentanyl patch face wrongful death lawsuit
The widower of a New York woman who allegedly died as a result of using a fentanyl patch is suing the product’s manufacturers.